Neuroblastoma detected by mass screening: The Tumor Board's role in its treatment

Pediatric Surgery International

Volumn 20, Issue 1, 2004, Pages 27-32

  Okazaki, Tadaharu ^a   Kohno, Sumio ^a   Mimaya, Jun Ichi ^a   Hasegawa, Shiro ^a   Urushihara, Naoto ^a   Yoshida, Atsushi ^a   Kawano, Shinya ^a   Kusafuka, Junichi ^a   Horikoshi, Yasuo ^a   Takashima, Yoshifumi ^a   Aoki, Katsuhiko ^a   Hamazaki, Minoru ^a  

^a SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

Author keywords

Mass screening; Neuroblastoma; Observation program

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; PIRARUBICIN; VINCRISTINE; CREATININE; HOMOVANILLIC ACID; MYC PROTEIN; VANILMANDELIC ACID;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FOLLOW UP; GENE AMPLIFICATION; GREAT BLOOD VESSEL; HISTOPATHOLOGY; HUMAN; INFANT; MASS SCREENING; NEUROBLASTOMA; PARENTAL CONSENT; PRIORITY JOURNAL; PROGNOSIS; TUMOR REGRESSION; TUMOR VOLUME; VERTEBRAL CANAL; ADRENAL TUMOR; COMPARATIVE STUDY; HOSPITAL; JAPAN; PATHOLOGY; RETROPERITONEAL TUMOR; TREATMENT OUTCOME; URINE;

ADRENAL GLAND NEOPLASMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CREATININE; FOLLOW-UP STUDIES; HOMOVANILLIC ACID; HOSPITALS, PEDIATRIC; HUMANS; INFANT; JAPAN; MASS SCREENING; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM STAGING; NEUROBLASTOMA; PARENTAL CONSENT; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; RETROPERITONEAL NEOPLASMS; TREATMENT OUTCOME; VANILMANDELIC ACID;

EID: 17844390384     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-003-1070-x     Document Type: Article

References (19)

1. Bernardi B de, Pianca C, Boni L et al. (1992) Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Cancer 70:1625-1633
2. Bernardi B de, Conte M, Mancini A et al. (1995) Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 13:884-893
3. Treuner J, Schilling FH (1995) Neuroblastoma mass screening: the arguments for and against. Eur J Cancer 31A: 565-568
4. Yamamoto K, Hayashi Y, Hanada R et al. (1995) Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan. J Clin Oncol 13:2033-2038
5. Bessho F, Hashizume K, Nakajo T et al. (1991) Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 119:237-241
6. Suita S, Tajiri T, Akazawa K et al. (1998) Mass screening for neuroblastoma at 6 months of age: difficult to justify. J Pediatr Surg 33:1674-1678
7. Woods WG, Tuchman M, Robinson LL et al. (1996) A population-based study of the usefulness of screening for neuroblastoma. Lancet 348:1682-1687
8. Yamamoto K, Kanada R, Kikuchi A et al. (1998) Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 16:1265-1269
9. Nishihira H, Toyoda Y, Tanaka Y et al. (2000) Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution. J Clin Oncol 18:3012-3017
10. Iwanaka T, Yamamoto K, Ogawa Y et al. (2001) Maturation of mass-screened localized adrenal neuroblastoma. J Pediatr Surg 36:1633-1636
11. Evans AE, D'Angio GJ, Randolph J (1971) A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer 27:374-378
12. Sawada T, Hirayama M, Nakata T et al. (1984) Mass screening for neuroblastoma in infants in Japan: interim report of a mass-screening group. Lancet 2:271-273
13. Nishi M, Miyake H, Takeda T et al. (1987) Effects of the mass screening of neuroblastoma in Sapporo City. Cancer 60:433-436
14. Woods WG, Gao RN, Shuster JJ et al. (2002) Screening of infants and mortality due to neuroblastoma. N Eng J Med 346:1041-1046
15. Schilling FH, Spix C, Berthold F et al. (2002) Neuroblastoma screening at one year of age. N Engl J Med 346:1047-1053
16. Tajiri T, Suita S, Sera Y et al. (2001) Clinical and biologic characteristics for recurring neuroblastoma in mass-screening cases in Japan. Cancer 92:349-353
17. Kaneko Y, Kanda N, Maseki N et al. (1990) Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a choromosome and N-myc amplification study. J Clin Oncol 8:2005-2013
18. Brodeur GM, Look AT, Shimada H et al. (2001) Biological aspects of neuroblastoma identified by mass screening in Quebec. Med Pediatr Oncol 36:157-159
19. Suita S (2002) Mass screening for neuroblastoma in Japan: lessons learned and future directions. J Pediatr Surg 37:949-954